← Back to Search

Behavioral Intervention

Language Model Assistance for Hospitalized Patients

N/A
Waitlist Available
Led By Xiaoxi Yao
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Minor patients (<18)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up three months
Awards & highlights
No Placebo-Only Group

Summary

This trial will test if using a tool called CURE to help write discharge summaries can improve patient care without causing any harm.

Who is the study for?
This trial is for hospitalized patients with aphasia, a condition that affects communication. The study will explore if using a large language model to assist in writing discharge summaries can improve care without negatively affecting patient outcomes.
What is being tested?
The intervention being tested is CURE, a large language model designed to help write discharge summaries for patients. The trial will determine its effectiveness and safety in clinical settings through a pragmatic, cluster-randomized controlled design.
What are the potential side effects?
Since the intervention involves software assistance rather than medication or medical procedures, traditional physical side effects are not applicable. However, potential risks may include inaccuracies in discharge notes impacting patient care.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am under 18 years old.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~three months
This trial's timeline: 3 weeks for screening, Varies for treatment, and three months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Rate of patient accrual

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Clinicians who care for patients randomized to intervention will have access to CURE to assist with discharge summary writing.
Group II: ControlActive Control1 Intervention
Clinicians who care for patients randomized to control will continue with standard practice for discharge summary writing.

Find a Location

Who is running the clinical trial?

Mayo ClinicLead Sponsor
3,339 Previous Clinical Trials
3,061,130 Total Patients Enrolled
8 Trials studying Aphasia
3,152 Patients Enrolled for Aphasia
Xiaoxi YaoPrincipal InvestigatorMayo Clinic
~677 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top